EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Congenital transmission of Chagas disease: The role of newborn therapy on the disease’s dynamics

Meriem Boukaabar, Bismark Oduro, Paul Chataa iD

PLOS ONE · 19.09.2024 · 19 (9) · e0308136

DOI: 10.1371/journal.pone.0308136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 19.09.2024. Verfasst von Meriem Boukaabar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mathematics, Pennsylvania Western University, California, PA, United States of America. Hauptthemen laut MEDLINE: Chagas Disease, Infectious Disease Transmission, Vertical. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chagas disease, also known as American trypanosomiasis, is caused by a protozoan blood-borne pathogen called Trypanosoma cruzi. The World Health Organization (WHO) has classified Chagas as one of 21 neglected tropical diseases present in the world and estimates that 6-7 million people are currently infected with Chagas. Congenital transmission of Chagas disease contributes to a significant amount of new infections, especially in endemic areas where 22.5% of new infections are due to congenital transmission. In this paper, we investigate congenital transmission’s impact on Chagas disease dynamics through a mathematical model. Specifically, we examine how treating a proportion of infants born to infected individuals impacts the progression and spread of Chagas disease. The influence of newborn therapy on the dynamics of the model is thoroughly investigated, both theoretically and numerically. The results illustrate the importance of treating a high proportion of newborns to reduce the number of infected cases of the disease. The findings show that the therapy given to newborns is necessary but not sufficient to curb the transmission of Chagas disease, and a comprehensive approach that includes vector and vertical transmission control strategies is essential for eradicating Chagas disease. We also observed that if vector transmission can be controlled, then at least 55% of the newborns need to be treated to eliminate the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chagas DiseaseInfectious Disease Transmission, VerticalHumansInfant, NewbornTrypanosoma cruziModels, TheoreticalAnimalsFemaleTrypanocidal Agents

Substanzen

Trypanocidal Agents

Autor:innen und Institutionen

  • Department of Mathematics, Pennsylvania Western University, California, PA, United States of America.
  • Department of Mathematics, University of Cape Coast, Cape Coast, Ghana.

ORCID-Profile: Paul Chataa

Zitieren

APA

Boukaabar, M., Oduro, B., & Chataa, P. (2024). Congenital transmission of Chagas disease: The role of newborn therapy on the disease’s dynamics. PLOS ONE, 19(9), e0308136. https://doi.org/10.1371/journal.pone.0308136

Vancouver

Boukaabar M, Oduro B, Chataa P. Congenital transmission of Chagas disease: The role of newborn therapy on the disease’s dynamics. PLOS ONE. 2024;19(9):e0308136. doi:10.1371/journal.pone.0308136

BibTeX
@article{Boukaabar2024,
  author = {Boukaabar, Meriem and Oduro, Bismark and Chataa, Paul},
  title = {Congenital transmission of Chagas disease: The role of newborn therapy on the disease’s dynamics},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {9},
  pages = {e0308136},
  doi = {10.1371/journal.pone.0308136}
}
Kostenlos starten →